Experimental CAR T-Cell therapy targets tough leukemias
Disease control
Recruiting now
This early-phase trial is testing an experimental treatment called CART84 for people with acute myeloid leukemia (AML) or T-cell acute lymphoblastic leukemia (T-ALL) that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified in a lab…
Phase: PHASE1, PHASE2 • Sponsor: Gyala Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC